Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimicrobial use, drug-resistant infections and COVID-19
Timothy M. Rawson, Damien Ming, Raheelah Ahmad, et al.
Nature Reviews Microbiology (2020) Vol. 18, Iss. 8, pp. 409-410
Open Access | Times Cited: 255

Showing 26-50 of 255 citing articles:

Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis
Sidra Khan, Syed Shahzad Hasan, Stuart Bond, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 5, pp. 749-772
Open Access | Times Cited: 70
COVID-19 and Antimicrobial Resistance: A Review
Yusuff Adebayo Adebisi, Aishat Jumoke Alaran, Melody Okereke, et al.
Infectious Diseases Research and Treatment (2021) Vol. 14
Open Access | Times Cited: 64
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit
Naouale Maataoui, Lotfi Chemali, Juliette Patrier, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 10, pp. 2227-2234
Open Access | Times Cited: 60
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
Alejandro David Bendala Estrada, Jorge Calderón‐Parra, Eduardo Fernández Carracedo, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 58
SARS-CoV-2: sewage surveillance as an early warning system and challenges in developing countries
Deepak Panchal, Om Prakash, Prakash Bobde, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 18, pp. 22221-22240
Open Access | Times Cited: 58
A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19
Srikanth Umakanthan, Vijay Kumar Chattu, Anu Vinod Ranade, et al.
AIMS Public Health (2021) Vol. 8, Iss. 1, pp. 137-153
Open Access | Times Cited: 55
Microbial Resistance to Antibiotics and Effective Antibiotherapy
Adriana Aurelia Chiș, Luca Liviu Rus, Claudiu Morgovan, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1121-1121
Open Access | Times Cited: 52
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 45
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidin
Elizabeth Michalczyk, Kay Hommernick, Iraj Behroz, et al.
Nature Catalysis (2023) Vol. 6, Iss. 1, pp. 52-67
Open Access | Times Cited: 29
Correlation between Antimicrobial Resistance and the Hospital-Wide Diverse Use of Broad-Spectrum Antibiotics by the Antimicrobial Stewardship Program in Japan
Takashi Ueda, Yoshio Takesue, Kazuhiko Nakajima, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 518-518
Open Access | Times Cited: 24
Superlattice Nanofilm on a Touchscreen for Photoexcited Bacteria and Virus Killing by Tuning Electronic Defects in the Heterointerface
Jun Li, Chaofeng Wang, Shuilin Wu, et al.
Advanced Materials (2023) Vol. 35, Iss. 22
Closed Access | Times Cited: 23
Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data
Xinyi Yang, Xiying Li, Shengyue Qiu, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106183-106183
Closed Access | Times Cited: 11
COVID-19 estimated to have increased plastics, diclofenac, and triclosan pollution in more than half of urban rivers worldwide
Qi Zhang, Carolien Kroeze, Shilei Cui, et al.
Cell Reports Sustainability (2024) Vol. 1, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 10
Versatile MOF@COF catalyzed and magnetically multivalent aptamer assisted biosensing platform for rapid and ultrasensitive dual-mode detection of multidrug-resistant bacteria
Ruiwen Li, Heng Fan, Hao Shen, et al.
Sensors and Actuators B Chemical (2024) Vol. 410, pp. 135719-135719
Closed Access | Times Cited: 9
Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017–2023: opportunities and gaps
Michela Sabbatucci, Diane Ashiru‐Oredope, Laura Barbier, et al.
Pharmacological Research (2024) Vol. 204, pp. 107188-107188
Open Access | Times Cited: 9
Dual Role of Baimao-Longdan-Congrong-Fang in Inhibiting Staphylococcus aureus Virulence Factors and Regulating TNF-α/TNFR1/NF-κB/MMP9 Axis
Tao Jiang, Xingxin Zhu, Zixin Yin, et al.
Phytomedicine (2025) Vol. 139, pp. 156477-156477
Closed Access | Times Cited: 1
The antibiotic paradox: why companies can’t afford to create life-saving drugs
Maryn McKenna
Nature (2020) Vol. 584, Iss. 7821, pp. 338-341
Closed Access | Times Cited: 64
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections
Ana Belén Guisado-Gil, Carmen Infante-Domínguez, Germán Peñalva, et al.
Antibiotics (2020) Vol. 9, Iss. 11, pp. 816-816
Open Access | Times Cited: 54
Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19
Chengyin Liu, Ying Wen, Weiguo Wan, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107157-107157
Open Access | Times Cited: 53
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks
Doris Rušić, Marino Vilović, Josipa Bukić, et al.
Life (2021) Vol. 11, Iss. 3, pp. 220-220
Open Access | Times Cited: 53
Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions
Viviane Maria de Carvalho Hessel Dias, Felipe Francisco Tuon, Patrícia de Jesus Capelo, et al.
Journal of Hospital Infection (2021) Vol. 120, pp. 43-47
Open Access | Times Cited: 51
An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan
Sayer Al‐Azzam, Nizar M. Mhaidat, Hayaa Abdallah Banat, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 690-690
Open Access | Times Cited: 46
Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital
Alice Ramos Oliveira Silva, Diamantino Salgado, Luís Phillipe Nagem Lopes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts
M. Nazmul Hoque, Md. Murshed Hasan Sarkar, M. Shaminur Rahman, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 42
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020
Nikolina Bogdanić, Loris Močibob, Toni Vidović, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263437-e0263437
Open Access | Times Cited: 37

Scroll to top